Pubfacts - Scientific Publication Data
  • Categories
  • |
  • Journals
  • |
  • Authors
  • Login
  • Categories
  • Journals

Search Our Scientific Publications & Authors

Publications
  • Publications
  • Authors
find publications by category +
Translate page:

Therapeutic effects of human STRO-3-selected mesenchymal precursor cells and their soluble factors in experimental myocardial ischemia.

Authors:
Fiona See Tetsunori Seki Peter J Psaltis Hugo P Sondermeijer Stan Gronthos Andrew C W Zannettino Klaas M Govaert Michael D Schuster Paul A Kurlansky Darren J Kelly Henry Krum Silviu Itescu

J Cell Mol Med 2011 Oct;15(10):2117-29

The University of Melbourne, St Vincent's Hospital, Department of Medicine, Melbourne, Victoria, Australia.

Stromal precursor antigen (STRO)-3 has previously been shown to identify a subset of adult human bone marrow (BM)-derived mesenchymal lineage precursors, which may have cardioprotective potential. We sought to characterize STRO-3-immunoselected and culture-expanded mesenchymal precursor cells (MPCs) with respect to their biology and therapeutic potential in myocardial ischemia. Immunoselection of STRO-3(+) MPCs enriched for fibroblastic colony forming units from unfractionated BM mononuclear cells (MNCs). Compared to mesenchymal stem cells conventionally isolated by plastic adherence, MPCs demonstrated increased proliferative capacity during culture expansion, expressed higher levels of early 'stem cell' markers and various pro-angiogenic and cardioprotective cytokines, and exhibited greater trilineage developmental efficiency. Intramyocardial injection of MPCs into a rat model of myocardial infarction (MI) promoted left ventricular recovery and inhibited left ventricular dilatation. These beneficial effects were associated with cardioprotective and pro-angiogenic effects at the tissue level, despite poor engraftment of cells. Treatment of MI rats with MPC-conditioned medium (CM) preserved left ventricular function and dimensions, reduced myocyte apoptosis and fibrosis, and augmented neovascularization, involving both resident vascular cells and circulating endothelial progenitor cells (EPCs). Profiling of CM revealed various cardioprotective and pro-angiogenic factors, which had biological activity in cultures of myocytes, tissue-resident vascular cells and EPCs. Prospective immunoselection of STRO-3(+) MPCs from BM MNCs conferred advantage in maintaining a population of immature MPCs during ex vivo expansion. Transplantation of culture-expanded MPCs into the post-MI heart resulted in therapeutic benefit, attributable at least in part to paracrine mechanisms of action. Thus, MPCs represent a promising therapy for myocardial ischemia.

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1582-4934.2010.01241.xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3092801PMC
October 2011

Publication Analysis

Top Keywords

left ventricular
12
myocardial ischemia
12
mpcs
8
cells
8
immunoselection stro-3+
8
vascular cells
8
cardioprotective pro-angiogenic
8
precursor cells
8
mesenchymal precursor
8
cells epcs
8
stro-3+ mpcs
8
associated cardioprotective
4
effects associated
4
beneficial effects
4
dilatation beneficial
4
ventricular dilatation
4
inhibited left
4
pro-angiogenic effects
4
recovery inhibited
4
tissue level
4

Keyword Occurance

Similar Publications

Fabry disease with acute myocardial infarction, left ventricular thrombosis, and pericardial effusion: A case report.

Authors:
Shanshan Zhou Xiaocong Wang Hui Xu Jing Li Liping Zhang Hang Li

Medicine (Baltimore) 2022 May 27;101(21):e29427. Epub 2022 May 27.

The Center of Cardiovascular Diseases, The First Hospital of Jilin University, Changchun, China.

Rationale: Fabry disease (FD) is a rare, X-linked lysosomal deposition disease characterized by multi-system symptoms. The accumulation of globotriaosylceramide in various organs, such as the kidneys and heart, as well as the nervous system, has been speculated to be the mechanism involved in tissue damage, including vascular impairment with thrombotic events.

Patient Concerns: Here, we describe a 72-year-old male patient diagnosed with FD, who first presented with acute myocardial infarction, left ventricular thrombosis, and pericardial effusion, accompanied by cardiac hypertrophy. Read More

View Article and Full-Text PDF
May 2022
Similar Publications

Low-Dose Propranolol Prevents Functional Decline in Catecholamine-Induced Acute Heart Failure in Rats.

Authors:
Cheng-Ken Tsai Bo-Hau Chen Hsin-Hung Chen Rebecca Jen-Ling Hsieh Jui-Chen Lee Yi-Ting Chu Wen-Hsien Lu

Toxics 2022 May 7;10(5). Epub 2022 May 7.

School of Medicine, National Yang-Ming University, Taipei 112, Taiwan.

Severe hyper-catecholaminergic states likely cause heart failure and cardiac fibrosis. While previous studies demonstrated the effects of beta-blockade in experimental models of single-catecholamine excess states, the detailed benefits of beta-blockade in more realistic models of hyper-adrenergic states are less clearly understood. In this study, we examined different therapeutic dosages and the effects of propranolol in rats with hyper-acute catecholamine-induced heart failure, and subsequent cardiopulmonary changes. Read More

View Article and Full-Text PDF
May 2022
Similar Publications

Metabolic Signatures of Pregnancy-Induced Cardiac Growth.

Authors:
Kyle L Fulghum Juliette B Smith Julia Chariker Lauren F Garrett Kenneth R Brittian Pawel Lorkiewicz Lindsey A McNally Shizuka Uchida Steven P Jones Bradford G Hill Helen E Collins

Am J Physiol Heart Circ Physiol 2022 May 27. Epub 2022 May 27.

Diabetes and Obesity Center, Christina Lee Brown Envirome Institute, Division of Environmental Medicine, Department of Medicine, University of Louisville, Louisville, KY, United States.

The goal of this study was to develop an atlas of the metabolic, transcriptional, and proteomic changes that occur with pregnancy in the maternal heart. Timed pregnancy studies in FVB/NJ mice revealed significant increases in heart size by day 8 of pregnancy (mid-pregnancy; MP), which was sustained throughout the rest of the term compared with non-pregnant controls. Cardiac hypertrophy and myocyte cross-sectional area were highest 7 d after birth (post-birth; PB) and were associated with significant increases in end-diastolic and end-systolic left ventricular volumes and cardiac output. Read More

View Article and Full-Text PDF
May 2022
Similar Publications

Myocardial Strain Evaluation with Cardiovascular MRI: Physics, Principles, and Clinical Applications.

Authors:
Prabhakar Shantha Rajiah Kevin Kalisz Jordi Broncano Harold Goerne Jeremy D Collins Christopher J François El-Sayed Ibrahim Prachi P Agarwal

Radiographics 2022 May 27:210174. Epub 2022 May 27.

From the Department of Radiology, Mayo Clinic, 200 1st St SW, Rochester, MN 559905 (P.S.R., J.D.C., C.J.F.); Department of Radiology, Duke University Medical Center, Durham, NC (K.K.); Department of Radiology, Hospital San Juan de Dios, Hospital de la Cruz Roja, HT-RESALTA, HT Médica, Córdoba, Spain (J.B.); Department of Radiology, Division of Cardiac Imaging, Imaging and Diagnostic Center CID, Guadalajara, Mexico (H.G.); Department of Radiology, Medical College of Wisconsin, Milwaukee, Wis (E.S.I.); and Department of Radiology, University of Michigan, Ann Arbor, Mich (P.P.A.).

Myocardial strain is a measure of myocardial deformation, which is a more sensitive imaging biomarker of myocardial disease than the commonly used ventricular ejection fraction. Although myocardial strain is commonly evaluated by using speckle-tracking echocardiography, cardiovascular MRI (CMR) is increasingly performed for this purpose. The most common CMR technique is feature tracking (FT), which involves postprocessing of routinely acquired cine MR images. Read More

View Article and Full-Text PDF
May 2022
Similar Publications

EKG Abnormalities in a Youth Athlete Following COVID-19: It's Not Always Myocarditis!

Authors:
Adam W Powell Elaine M Urbina William B Orr Jesse E Hansen Shankar Baskar

Pediatr Cardiol 2022 May 27. Epub 2022 May 27.

Department of Pediatrics, University of Cincinnati College of Medicine, 3333 Burnett Avenue, MLC 2003, Cincinnati, OH, 45229-3026, USA.

COVID-19 associated myocarditis following mild infections is rare while incidental findings may be more common. A young athlete fully recovered from a mild COVID-19 infection presented with inferolateral T-wave inversions and left ventricular hypertrophy on imaging. Exercise testing aided in correctly diagnosing the patient with masked systolic hypertension. Read More

View Article and Full-Text PDF
May 2022
Similar Publications
}
© 2022 PubFacts.
  • About PubFacts
  • Privacy Policy
  • Sitemap